Identification of antitumor constituents in curcuminoids from Curcuma longa L. based on the composition-activity relationship

Journal of Pharmaceutical and Biomedical Analysis

Volumn 70, Issue , 2012, Pages 664-670

  Jiang, Jian Lan ^a   Jin, Xiao Li ^a   Zhang, Huan ^a   Su, Xin ^a   Qiao, Bin ^a   Yuan, Ying Jin ^a  

^a TIANJIN UNIVERSITY   (China)

Author keywords

Antitumor activity; Correlation analysis; Curcuma longa L.; Curcuminoids; HPLC ESI MS MS analysis

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CURCUMIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; COMPUTER PROGRAM; CONTROLLED STUDY; CORRELATION ANALYSIS; CURCUMA LONGA; DRUG DETERMINATION; DRUG ISOLATION; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; HELA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PARTIAL LEAST SQUARES REGRESSION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STRUCTURE ACTIVITY RELATION;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL PROLIFERATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CURCUMA; CURCUMIN; DRUG DISCOVERY; HELA CELLS; HUMANS; LEAST-SQUARES ANALYSIS; PLANTS, MEDICINAL; REPRODUCIBILITY OF RESULTS; SOFTWARE; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STRUCTURE-ACTIVITY RELATIONSHIP; TANDEM MASS SPECTROMETRY;

EID: 84866263407     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.05.011     Document Type: Article

References (19)

1. China Pharmacopoeia Committee Pharmacopoeia of the People's Republic of China 2010, China Medical Science and Technology Press, Beijing, 247-248.
2. Kuttan R., Bhanumathy P., Nirmala K., George M.C. Potential anticancer activity of turmeric (Curcuma longa). Cancer Lett. 1985, 29:197-202.
3. Anonymous Clinical development plan: curcumin. J. Cell. Biochem. (Suppl.) 1996, 26:72-85.
4. Nishiyama T., Mae T., Kishida H., Tsukagawa M., Mimaki Y., Kuroda M., Sashida Y., Takahashi K., Kawada T., Nakagawa K., Kitahara M. Curcuminoids and sesquiterpenoids in turmeric (Curcuma longa L.) suppress an increase in blood glucose level in type 2 diabetic KK-Ay mice. J. Agric. Food Chem. 2005, 53:959-963.
5. Zeng Y.C., Qiu F., Takahashi K., Liang J.M., Qu G.X., Yao X.S. New sesquiterpenes and calebin derivatives from Curcuma longa. Chem. Pharm. Bull. 2007, 55:940-943.
6. Liang G., Tian J.L., Shao L.L., Yang S.L., Li X.K. Progress in the research on SAR and development of antitumor curcuminoids. Chem. Bull. 2008, 2:110-111.
7. Park S.Y., Kim D.S. Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: a drug discovery effort against Alzheimer's disease. J. Nat. Prod. 2002, 65:1227-1231.
8. Kiuchi F., Iwakami S., Shibuya M., Hanaoka F., Sankawa U. Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem. Pharm. Bull. 1992, 40:387-391.
9. Masuda T., Isobe J., Jitoe A., Nakatani N. Antioxidative curcuminoids from rhizomes of Curcuma, Xanthorrhiza. Phytochemistry 1992, 31. 3645-3647.
10. Masuda T., Jitoe A., Isobe J., Nakatani N., Yonemori S. Anti-oxidative and anti-inflammatory curcumin-related phenolics from rhizomes of Curcuma domestica. Phytochemistry 1993, 32:1557-1560.
11. Bai Y.F., Li H.X., Wang C.F., Yu X.L., Qiu Y.X., Wang Y.M. Study on the constituents of yellow pigments from the Rhizome of Curcuma longa. China Med. Her. 2010, 7:46-48.
12. Bylesjo M., Rantalainen M., Cloarec O., Nicholson J.K., Holmes E., Trygg J. OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification. J. Chemom. 2006, 20:341-351.
13. Wiklund S., Johansson E., Sjostrom L., Mellerowicz E.J., Edlund U., Shockcor J.P., Gottfries J., Moritz T., Trygg J. Visualization of GC/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models. Anal. Chem. 2008, 80:115-122.
14. J.L. Jiang, X.L. Jin, B. Qiao, Y.J. Yuan, Analysis of curcuminoids in Curcuma longa L. by HPLC-ESI-MS/MS, Nat. Prod. Res. Dev. (2012), in press.
15. Liu Y.X., Zhu X.L., Chen Y.H., Guo F., Shen M., Chen Z.G., Xu W., Chen D.Y., Tao Z.H. Metabolomic profiles in prostate cancer cells progression. Chin. J. Anal. Chem. 2011, 39:305-311.
16. Adams B.K., Ferstl E.M., Davis M.C., Herold M., Kurtkaya S., Camalier R.F., Hollingshead M.G., Kaur G., Sausville E.A., Rickles F.R., Snyder J.P., Liotta D.C., Shoji M. Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents. Bioorg. Med. Chem. 2004, 12:3871-3883.
17. Li L., Shi Q., Su C.Y., Shih C.C., Lee K.H. Antitumor agents 247. New 4-ethoxycarbonylethyl curcumin analogs as potential antiandrogenic agents. Bioorg. Med. Chem. 2006, 14:2527-2534.
18. Lin L., Shi Q., Nyarko A.K., Bastow K.F., Wu C.C., Su C.Y., Lee K.H. Antitumor agents 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents. J. Med. Chem. 2006, 49:3963-3972.
19. Talalay P. The importance of using scientific principles in the development of medicinal agents from plants. Acad. Med. 2001, 76:238-247.